---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-030940"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T12:45:00.750642+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioCardia Q3 net loss narrows to $2.6M; CardiAMP HF trial paused after DSMB review

## Summary
- Q3 2023 revenue $357K (up 68% YoY); net loss $2.6M improves from $3.1M YoY.
- DSMB recommended pause of CardiAMP HF trial; management agrees primary endpoint unlikely with current design.
- Subset analysis: NT-proBNP>500 patients showed 59% relative risk reduction in mortality (p=0.028).
- Company submitted new protocol (CardiAMP HF II) to FDA targeting responders; Japan PMDA consultation set for Nov 21.
- Cash used in operations $2.4M; anticipates two Helix licensing/development partnerships in Q4 2023.

## SEC filing metadata
- accession: 0001437749-23-030940
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774923030940/0001437749-23-030940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774923030940/bcda20231107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-030940
- JSON: https://secwatch.observer/filing/0001437749-23-030940.json
- Plain text: https://secwatch.observer/filing/0001437749-23-030940.txt

## Key facts
- Earnings Releases
  BioCardia, Inc. reported financial results for the quarter ended September 30, 2023.
  - Period: the quarter ended September 30, 2023
  - Result: reported results
  source text: On November 8, 2023, BioCardia, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/925741/000143774923030940/0001437749-23-030940-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.